Patent ID: 11944636
Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A medicinal composition for preventing and/or treating cancer comprising a non-coding RNA molecule and an antibody targeting a tumor antigen,
wherein the non-coding RNA molecule is a tRNA molecule comprising an antisense strand having a sequence identity of at least 90% with respect to SEQ ID NO: 1, and a sense strand having a sequence identity of at least 90% with respect to SEQ ID NO: 2, and
wherein the antibody targets a PD-1 tumor antigen; and
wherein said non-coding RNA molecule and said antibody targeting a tumor antigen may be administered to a patient as a mixture of said non-coding RNA molecule and said antibody targeting a tumor antigen; or said non-coding RNA molecule and said antibody targeting a tumor antigen may be administered to a patient separately.